Ana Maria Chindris, M.D.

89% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024

287 Medicare Part D claims for 89 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 54% of claims.

Most prescribed

1. Levothyroxine Sodium100 claims
2. Synthroid74 claims
3. Risedronate Sodium19 claims
4. Alendronate Sodium16 claims
5. Hydrocortisone13 claims
6. Methimazole12 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 76.2 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Bills Medicare through one group practice

1. Mayo Clinic JacksonvilleJacksonville, FL

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).